Filtered By:
Cancer: Oral Cancer
Drug: Lortab
This page shows you your search results in order of date.
Order by Relevance | Date
Total 114 results found since Jan 2013.
Rectus sheath catheters reduce opiate use in pancreaticoduodenectomy: a pre- and postintervention cohort study
CONCLUSION: The use of RSCs was associated with significant reductions in postoperative opiate consumption. Given the ease of placement and management, with minimal complications, RSCs should be incorporated into a course of postoperative multimodal analgesia. A large scale randomized controlled trial should be conducted to further investigate these findings.PMID:37442583 | DOI:10.1503/cjs.006922
Source: Canadian Journal of Surgery - July 13, 2023 Category: Surgery Authors: Patrick L C Tapley Martin Van der Vyver Natalie G Coburn Julie Hallet Calvin Law Rachel Roke Paul J Karanicolas Source Type: research
Gefitinib-induced Myositis: A Novel Case Report
Yakugaku Zasshi. 2023;143(7):617-620. doi: 10.1248/yakushi.23-00007.ABSTRACTChemotherapy-induced myositis is a severe adverse event caused by chemotherapeutic agents such as immune checkpoint inhibitors (ICIs) or cytotoxic agents. We experienced a patient with gefitinib-induced myositis with symptoms of muscle cramps and stiffness in the limbs, and reported the treatment process. A 70-year-old woman received four courses of carboplatin (CBDCA)+pemetrexed (PEM)+gefitinib (intravenous CBDCA area under the curve (AUC) 5 and PEM 500 mg/m2, every 3 weeks, and oral gefitinib 250 mg daily), for epidermal growth factor receptor (E...
Source: Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan - July 2, 2023 Category: Drugs & Pharmacology Authors: Tatsuhiko Sakamoto Yoshitaka Saito Yoh Takekuma Eiki Kikuchi Mitsuru Sugawara Source Type: research
